Par Pharmaceutical Companies, Inc. (NYSE:PRX)

rammsteinman (74.23) Submitted: 7/4/2007 4:50:31 AM : Start Price: $30.30 PRX Score: +43.67

cant lose with pharmaceuticals right now

TMFStockPick07 (40.42) Submitted: 5/21/2007 6:27:16 PM : Start Price: $28.51 PRX Score: +51.93

This stock was picked to outperform from May 2007 to May 2008 by TMFRobert

Spooky27 (96.06) Submitted: 3/4/2007 10:31:08 PM : Start Price: $23.29 PRX Score: +73.87

Well this company is health the eps is -0.05 but the chart show a possiable turn around there maybe room for profitablity but growth will be slow,not so good!

ICHIBANKOI (41.41) Submitted: 2/26/2007 5:05:46 PM : Start Price: $24.55 PRX Score: +69.07

Has buyout written all over them

00746angel (< 20) Submitted: 2/18/2007 8:28:31 PM : Start Price: $24.43 PRX Score: +71.01

shipping out new approved drugs
as fast as they can produce them
pipe lines need to be filled
also esclusive rights for six months

tex41 (< 20) Submitted: 2/7/2007 11:17:36 PM : Start Price: $26.80 PRX Score: +55.69

Pure numbers pick. I like the likelhood government will legislate support for generic drugs , stock undergoing heavy trading last 10 days, up price during this volumn and lastly indoral prospective for adding quickly to bottom line. Oh the numbers? See TMFOTTER's list of rejects. This one has turned around and is headed up bigtime.

fibreoptik (89.06) Submitted: 12/20/2006 1:34:57 AM : Start Price: $21.33 PRX Score: +93.12

More and more old people means more and more demand for drugs. Generics are cheaper and many old folks are unfortunately not very well off so the generics are going to do quite well.

There's a party at Shadey Pines and everyone is invited. It's BYOF though - Bring Your Own Fixa-dent ;-)

nysuburbanite (47.98) Submitted: 10/24/2006 1:04:17 PM : Start Price: $19.76 PRX Score: +104.46

Generic drug business will have an increasing impact on US healthcare, and PRX has a growing network of partners and distributors.

Also, if the Dems win the Senate, it could be a boon for the entire industry.

fergus101 (80.71) Submitted: 10/3/2006 9:26:59 PM : Start Price: $17.65 PRX Score: +126.17

Par Pharmaceutical is in the generic drug busines. It is a good industry to be in and Par has developed a strong pipeline. They have recently axed the CEO/President after some accounting irregularities, for which the stock price was hit hard. They may need a couple of quarters to sort out their management troubles, but with a new management team in place there is definitely light at the end of this tunnel. This is a turn round play, and my feeling is that we have reached the bottom, and are starting to come up the other side.